View in EDS HTML Full Text PDF Full Text

Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.

Saved in:
Bibliographic Details
Title: Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
Authors: El-Sisi AE; Pharmacology and Toxicology department, College of Pharmacy, University of Tanta, Tanta, Egypt., Sokkar SS; Pharmacology and Toxicology department, College of Pharmacy, University of Tanta, Tanta, Egypt., Ibrahim HA; Pharmacology and Toxicology department, College of Pharmacy, University of Tanta, Tanta, Egypt., Hamed MF; Department of Pathology, College of Veterinary Medicine, University of El-Mansoura, Mansoura, Egypt., Abu-Risha SE; Pharmacology and Toxicology department, College of Pharmacy, University of Tanta, Tanta, Egypt.
Source: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2020 Aug; Vol. 34 (4), pp. 458-475. Date of Electronic Publication: 2020 Mar 12.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 8710411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-8206 (Electronic) Linking ISSN: 07673981 NLM ISO Abbreviation: Fundam Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32080901
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22El-Sisi+AE%22">El-Sisi AE</searchLink>; Pharmacology and Toxicology department, College of Pharmacy, University of Tanta, Tanta, Egypt.<br /><searchLink fieldCode="AU" term="%22Sokkar+SS%22">Sokkar SS</searchLink>; Pharmacology and Toxicology department, College of Pharmacy, University of Tanta, Tanta, Egypt.<br /><searchLink fieldCode="AU" term="%22Ibrahim+HA%22">Ibrahim HA</searchLink>; Pharmacology and Toxicology department, College of Pharmacy, University of Tanta, Tanta, Egypt.<br /><searchLink fieldCode="AU" term="%22Hamed+MF%22">Hamed MF</searchLink>; Department of Pathology, College of Veterinary Medicine, University of El-Mansoura, Mansoura, Egypt.<br /><searchLink fieldCode="AU" term="%22Abu-Risha+SE%22">Abu-Risha SE</searchLink>; Pharmacology and Toxicology department, College of Pharmacy, University of Tanta, Tanta, Egypt.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228710411%22">Fundamental & clinical pharmacology</searchLink> [Fundam Clin Pharmacol] 2020 Aug; Vol. 34 (4), pp. 458-475. <i>Date of Electronic Publication: </i>2020 Mar 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8710411 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1472-8206 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207673981%22">07673981 </searchLink><i>NLM ISO Abbreviation: </i>Fundam Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32080901
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/fcp.12549
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 458
    Titles:
      – TitleFull: Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: El-Sisi AE
      – PersonEntity:
          Name:
            NameFull: Sokkar SS
      – PersonEntity:
          Name:
            NameFull: Ibrahim HA
      – PersonEntity:
          Name:
            NameFull: Hamed MF
      – PersonEntity:
          Name:
            NameFull: Abu-Risha SE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2020 Aug
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1472-8206
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Fundamental & clinical pharmacology
              Type: main
ResultId 1